wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34132767-3502248B-5419-4622-84B3-DC0E6582C4F6
Q34132767-3502248B-5419-4622-84B3-DC0E6582C4F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132767-3502248B-5419-4622-84B3-DC0E6582C4F6
Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
P2860
Q34132767-3502248B-5419-4622-84B3-DC0E6582C4F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34132767-3502248B-5419-4622-84B3-DC0E6582C4F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4cc74970f6e9997bd3e5c562d13d3a138170e54
P2860
Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.